E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/16/2006 in the Prospect News Biotech Daily.

Lifestream Technologies sells assets for $4.5 million

By Elaine Rigoli

Tampa, Fla., May 16 - Lifestream Technologies, Inc. said it has entered into a patent and trademark assignment and license assumption agreement with RAB Special Situations Fund Ltd.

Lifestream assigned to RAB the rights, titles and interest in certain patent applications, trademarks and related license agreements in exchange for the cancelation of $4.5 million of secured and unsecured debt, according to a news release.

Located in Post Falls, Idaho, Lifestream develops and markets cholesterol monitors.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.